Your browser doesn't support javascript.
loading
Immunoglobulin G genetic variation can confound assessment of antibody levels via altered binding to detection reagents.
Purcell, Ruth A; Aurelia, L Carissa; Esterbauer, Robyn; Allen, Lilith F; Bond, Katherine A; Williamson, Deborah A; Trevillyan, Janine M; Trubiano, Jason A; Juno, Jennifer J; Wheatley, Adam K; Davenport, Miles P; Nguyen, Thi Ho; Kedzierska, Katherine; Kent, Stephen J; Selva, Kevin John; Chung, Amy W.
Afiliación
  • Purcell RA; Department of Microbiology and Immunology The Peter Doherty Institute for Infection and Immunity, University of Melbourne Melbourne VIC Australia.
  • Aurelia LC; Department of Microbiology and Immunology The Peter Doherty Institute for Infection and Immunity, University of Melbourne Melbourne VIC Australia.
  • Esterbauer R; Department of Microbiology and Immunology The Peter Doherty Institute for Infection and Immunity, University of Melbourne Melbourne VIC Australia.
  • Allen LF; Department of Microbiology and Immunology The Peter Doherty Institute for Infection and Immunity, University of Melbourne Melbourne VIC Australia.
  • Bond KA; Department of Microbiology and Immunology The Peter Doherty Institute for Infection and Immunity, University of Melbourne Melbourne VIC Australia.
  • Williamson DA; Victorian Infectious Diseases Reference Laboratory (VIDRL) The Peter Doherty Institute for Infection and Immunity Melbourne VIC Australia.
  • Trevillyan JM; Victorian Infectious Diseases Reference Laboratory (VIDRL) The Peter Doherty Institute for Infection and Immunity Melbourne VIC Australia.
  • Trubiano JA; Walter and Eliza Hall Institute of Medical Research Parkville VIC Australia.
  • Juno JJ; Department of Infectious Diseases The Peter Doherty Institute for Infection and Immunity, University of Melbourne Melbourne VIC Australia.
  • Wheatley AK; Department of Infectious Diseases The Peter Doherty Institute for Infection and Immunity, University of Melbourne Melbourne VIC Australia.
  • Davenport MP; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases Austin Health Heidelberg VIC Australia.
  • Nguyen TH; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases Austin Health Heidelberg VIC Australia.
  • Kedzierska K; Department of Medicine University of Melbourne Parkville VIC Australia.
  • Kent SJ; Department of Infectious Diseases Peter MacCallum Cancer Centre Melbourne VIC Australia.
  • Selva KJ; National Centre for Infections in Cancer Peter MacCallum Cancer Centre Melbourne VIC Australia.
  • Chung AW; Department of Microbiology and Immunology The Peter Doherty Institute for Infection and Immunity, University of Melbourne Melbourne VIC Australia.
Clin Transl Immunology ; 13(3): e1494, 2024.
Article en En | MEDLINE | ID: mdl-38433763
ABSTRACT

Objectives:

Amino acid variations across more than 30 immunoglobulin (Ig) allotypes may introduce structural changes that influence recognition by anti-Ig detection reagents, consequently confounding interpretation of antibody responses, particularly in genetically diverse cohorts. Here, we assessed a panel of commercial monoclonal anti-IgG1 clones for capacity to universally recognise two dominant IgG1 haplotypes (G1m-1,3 and G1m1,17).

Methods:

Four commercial monoclonal anti-human IgG1 clones were assessed via ELISAs and multiplex bead-based assays for their ability to bind G1m-1,3 and G1m1,17 IgG1 variants. Detection antibodies were validated against monoclonal IgG1 allotype standards and tested for capacity to recognise antigen-specific plasma IgG1 from G1m-1,3 and G1m1,17 homozygous and heterozygous SARS-CoV-2 BNT162b2 vaccinated (n = 28) and COVID-19 convalescent (n = 44) individuals. An Fc-specific pan-IgG detection antibody corroborated differences between hinge- and Fc-specific anti-IgG1 responses.

Results:

Hinge-specific anti-IgG1 clone 4E3 preferentially bound G1m1,17 compared to G1m-1,3 IgG1. Consequently, SARS-CoV-2 Spike-specific IgG1 levels detected in G1m1,17/G1m1,17 BNT162b2 vaccinees appeared 9- to 17-fold higher than in G1m-1,3/G1m-1,3 vaccinees. Fc-specific IgG1 and pan-IgG detection antibodies equivalently bound G1m-1,3 and G1m1,17 IgG1 variants, and detected comparable Spike-specific IgG1 levels between haplotypes. IgG1 responses against other human coronaviruses and influenza were similarly poorly detected by 4E3 anti-IgG1 in G1m-1,3/G1m-1,3 subjects.

Conclusion:

Anti-IgG1 clone 4E3 confounds assessment of antibody responses in clinical cohorts owing to bias towards detection of G1m1,17 IgG1 variants. Validation of anti-Ig clones should include evaluation of binding to relevant antibody variants, particularly as the role of immunogenetics upon humoral immunity is increasingly explored in diverse populations.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Clin Transl Immunology Año: 2024 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Clin Transl Immunology Año: 2024 Tipo del documento: Article